DAPP1

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, DAPP1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated DAPP1 data layer compared with 23 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher DAPP1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated DAPP1 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

HNSC, PDAC, and CCRCC are the cancer types where DAPP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
HNSCOSTertileAll0.8380.586.00631view →
PDACOSMedianIII,IV0.5910.976.00215view →
CCRCCDFSQuartileIII,IV0.2450.819.00910view →
LUADOSMedianAll0.5980.949.0015view →
Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

DAPP1–HNSC (OS)

Kaplan–Meier survival curve for DAPP1 mass-spec protein-high vs -low samples in HNSC.

Open the HNSC breakdown →

Exploration